- Filed
- Apr 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2025 | 30.98M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 26.75M sh |
| Capex | FY 2024 · Dec 31, 2023 | $3.72M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $814K |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $265K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $10.77M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $22.42M |
| Current Assets | FY 2024 · Dec 31, 2023 | $37.43M |
| Total Assets | FY 2024 · Dec 31, 2023 | $57.52M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.45 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.45 |
| Net Income | FY 2024 · Dec 31, 2023 | −$12.15M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$13.07M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $48.8M |